GFAP and Alzheimer disease: GFAP levels were meta-analyzed among 2,425 patients on the AD continuum (12 cohorts MCI-AD n = 404, 19 cohorts AD dementia n = 1,568, 6 cohorts AD dementia + MCI-AD n = 453) and 3,168 CU individuals (27 cohorts).